{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:54:05Z","timestamp":1759366445464,"version":"build-2065373602"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.revmed.2009.02.027","type":"journal-article","created":{"date-parts":[[2009,9,20]],"date-time":"2009-09-20T04:32:20Z","timestamp":1253421140000},"page":"72-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Associations antifongiques dans les infections fongiques invasives"],"prefix":"10.1016","volume":"31","author":[{"given":"J.","family":"Gellen-Dautremer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lanternier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Dannaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2009.02.027_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijantimicag.2006.01.002","article-title":"Candidaemia in Europe: epidemiology and resistance","volume":"27","author":"Tortorano","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.revmed.2009.02.027_bib2","article-title":"Epidemiology, management and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005\u20132006)","author":"Leroy","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.revmed.2009.02.027_bib3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey","volume":"43","author":"Cornillet","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2009.02.027_bib4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/QAI.0b013e31811ed32c","article-title":"Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients","volume":"45","author":"Micol","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.revmed.2009.02.027_bib5","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/01.aids.0000252060.80704.68","article-title":"Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy","volume":"20","author":"Lortholary","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.revmed.2009.02.027_bib6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2009.02.027_bib7","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/374850","article-title":"A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects","volume":"36","author":"Rex","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2009.02.027_bib8","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","article-title":"Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America","volume":"30","author":"Saag","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2009.02.027_bib9","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2009.02.027_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/508774","article-title":"Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2009.02.027_bib11","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/423381","article-title":"Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy","volume":"39","author":"Maertens","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2009.02.027_bib12","first-page":"5","article-title":"Prise en charge des aspergilloses et candidoses invasives de l\u2019adulte. Conf\u00e9rence de consensus commune SFAR, SPILF, SRLF","author":"Regnier","year":"2004","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.revmed.2009.02.027_bib13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2009.02.027_bib14","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/AAC.48.3.970-978.2004","article-title":"In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus","volume":"48","author":"Dannaoui","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJM197907193010303","article-title":"A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis","volume":"301","author":"Bennett","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2009.02.027_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Gro*up and AIDS Clinical Trials Group","volume":"337","author":"van der Horst","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2009.02.027_bib17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJM198708063170602","article-title":"Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks","volume":"317","author":"Dismukes","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2009.02.027_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7326\/0003-4819-113-3-183","article-title":"Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial","volume":"113","author":"Larsen","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2009.02.027_bib19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/clinids\/19.4.741","article-title":"Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS","volume":"19","author":"Larsen","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2009.02.027_bib20","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","article-title":"Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial","volume":"363","author":"Brouwer","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2009.02.027_bib21","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1128\/AAC.46.9.2982-2989.2002","article-title":"In vitro interaction of flucytosine combined with amphotericin B or fluconazole against thirty-five yeast isolates determined by both the fractional inhibitory concentration index and the response surface approach","volume":"46","author":"Te Dorsthorst","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/infdis\/131.2.129","article-title":"Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice","volume":"131","author":"Hamilton","year":"1975","journal-title":"J Infect Dis"},{"key":"10.1016\/j.revmed.2009.02.027_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/AAC.00446-06","article-title":"Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans","volume":"51","author":"Schwarz","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/AAC.50.1.113-120.2006","article-title":"Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis","volume":"50","author":"Schwarz","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/515110","article-title":"A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"28","author":"Saag","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2009.02.027_bib26","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pmed.0040021","article-title":"Determinants of disease presentation and outcome during cryptococcosis: the CryptoA\/D study","volume":"4","author":"Dromer","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.revmed.2009.02.027_bib27","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1128\/AAC.48.3.985-991.2004","article-title":"Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis","volume":"48","author":"Larsen","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib28","unstructured":"Pappas PG NT, Chetchotisakd P, Larsen R, Manosuthi W, Filler S. Fluconazole plus amphotericin B(AmB) versus AmB alone for primary treatment of AIDS-associated cryptococcal meningitis: results of a phase II trial. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago (USA); 2007; Abstract M-626."},{"key":"10.1016\/j.revmed.2009.02.027_bib29","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1128\/AAC.39.8.1691","article-title":"In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans","volume":"39","author":"Nguyen","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib30","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1128\/AAC.47.10.3361-3364.2003","article-title":"In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates","volume":"47","author":"Schwarz","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib31","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/jac\/48.6.769","article-title":"Activity of the new antifungal triazole, posaconazole, against Cryptococcus neoformans","volume":"48","author":"Barchiesi","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib32","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/AAC.01140-07","article-title":"Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005\u20132006","volume":"52","author":"Dannaoui","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/AAC.41.2.331","article-title":"Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro","volume":"41","author":"Franzot","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.tp.0000202421.94822.f7","article-title":"Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study","volume":"81","author":"Singh","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.revmed.2009.02.027_bib35","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/423380","article-title":"Combination antifungal therapy for invasive aspergillosis","volume":"39","author":"Marr","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2009.02.027_bib36","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1002\/cncr.22348","article-title":"Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis","volume":"107","author":"Maertens","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.revmed.2009.02.027_bib37","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cncr.11479","article-title":"Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies","volume":"98","author":"Kontoyiannis","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.revmed.2009.02.027_bib38","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/cncr.11115","article-title":"Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin","volume":"97","author":"Aliff","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.revmed.2009.02.027_bib39","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/cncr.23109","article-title":"Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial)","volume":"110","author":"Caillot","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.revmed.2009.02.027_bib40","first-page":"60","article-title":"Associations d\u2019antifongiques. Conf\u00e9rence de consensus commune SFAR, SPILF, SRLF","author":"Lortholary","year":"2004","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.revmed.2009.02.027_bib41","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1002\/cncr.21057","article-title":"Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis","volume":"103","author":"Kontoyiannis","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.revmed.2009.02.027_bib42","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/AAC.49.8.3572-3574.2005","article-title":"In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp","volume":"49","author":"Philip","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib43","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/AAC.46.9.3039-3041.2002","article-title":"In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp","volume":"46","author":"Perea","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib44","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1128\/AAC.00829-05","article-title":"Interaction between posaconazole and caspofungin in concomitant treatment of mice with systemic Aspergillus infection","volume":"50","author":"Cacciapuoti","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib45","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","article-title":"Combination antifungal therapy","volume":"48","author":"Johnson","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib46","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1128\/AAC.49.9.3697-3701.2005","article-title":"Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis","volume":"49","author":"MacCallum","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/AAC.46.1.245-247.2002","article-title":"In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp","volume":"46","author":"Arikan","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib48","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1128\/AAC.49.12.4867-4875.2005","article-title":"Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis","volume":"49","author":"Clemons","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib49","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/jac\/dki178","article-title":"Efficacy of Abelcet and caspofungin, alone or in combination, against CNS aspergillosis in a murine model","volume":"56","author":"Imai","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jinf.2005.10.015","article-title":"Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis","volume":"53","author":"Sionov","year":"2006","journal-title":"J Infect"},{"key":"10.1016\/j.revmed.2009.02.027_bib51","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1128\/AAC.50.2.422-427.2006","article-title":"Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-\/- mouse model of chronic granulomatous disease","volume":"50","author":"Dennis","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib52","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/506617","article-title":"Triazole-polyene antagonism in experimental invasive pulmonary aspergillosis: in vitro and in vivo correlation","volume":"194","author":"Meletiadis","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.revmed.2009.02.027_bib53","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/AAC.01024-06","article-title":"Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro","volume":"51","author":"Perkhofer","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib54","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/clinids\/12.6.1147","article-title":"Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases","volume":"12","author":"Denning","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.revmed.2009.02.027_bib55","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 5","key":"10.1016\/j.revmed.2009.02.027_bib56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejcsup.2007.06.007","article-title":"Treatment of invasive Candida and invasive Aspergillus in adult haematological patients","author":"Herbrecht","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.revmed.2009.02.027_bib57","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1128\/AAC.49.2.638-642.2005","article-title":"Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivo","volume":"49","author":"Cacciapuoti","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib58","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1128\/AAC.49.12.4895-4902.2005","article-title":"Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin","volume":"49","author":"Olson","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.revmed.2009.02.027_bib59","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3181\/00379727-138-35943","article-title":"Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms","volume":"138","author":"Medoff","year":"1971","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.revmed.2009.02.027_bib60","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/01.tp.0000235988.51610.f7","article-title":"Antifungal alternatives for invasive candidiasis refractory to caspofungin in liver transplant recipients: a report of two cases","volume":"82","author":"Choukroun","year":"2006","journal-title":"Transplantation"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866309001453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866309001453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:25:41Z","timestamp":1759335941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866309001453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0248866309001453"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2009.02.027","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations antifongiques dans les infections fongiques invasives","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2009.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}